Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | PGD | P52209 | 3/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL536485 | 1.00 | PDE4A (0.47) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL526989 | 0.95 | PDE4A (0.39) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Demannose SCHEMBL4340605 | 0.89 | PDE4A (0.39) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL4314209 | 0.86 | PDE4A (0.36) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL8580151 | 0.83 | LMNA (0.37) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL10699708 | 0.83 | USP2 (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL8582227 | 0.83 | LMNA (0.37) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Mannitol SCHEMBL28986333 | 0.80 | LMNA (0.55) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL360335 | 0.79 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL6282106 | 0.79 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465616-B1 | TREATMENT OF STATIN SIDE EFFECTS USING URIDINE DERIVATIVES | MAGRAL LTD (AU) | 2010-06-30 | — | — | EP | claimed |
| EP-1054062-B1 | GLYCOSYLTRANSFERASE AND DNA ENCODING THE SAME | KYOWA HAKKO BIO CO LTD (JP) | 2009-06-03 | — | — | EP | claimed |
| US-7238100-B2 | β1,3-galactosyltransferase and DNA encoding the same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-07-03 | — | — | US | claimed |
| US-20240336946-A1 | SOLID-PHASE GLYCAN REMODELING OF GLYCOPROTEINS | MERCK SHARP & DOHME LLC (US) | 2024-10-10 | — | — | US | disclosed |
| EP-4110391-A1 | ENZYMES FOR SIALYLATION OF GLYCANS | Momenta Pharmaceuticals, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| WO-2009025646-A1 | ALPHA 1-3 N-GALACTOSYLTRANSFERASE WITH ALTERED DONOR SPECIFICITIES | GOVERNMENT OF THE U.S.A, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2009-02-26 | — | — | WO | disclosed |
| EP-1801118-A1 | PROCESS FOR SYNTHESIS OF MUCIN-TYPE PEPTIDES AND MUC1-RELATED GLYCOPEPTIDES | SHIONOGI & CO., LTD. (JP) | 2007-06-27 | — | — | EP | disclosed |